IRIS
D'ANNA, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.253
NA - Nord America 8.251
AS - Asia 4.304
SA - Sud America 1.503
Continente sconosciuto - Info sul continente non disponibili 271
AF - Africa 130
OC - Oceania 15
Totale 23.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.068
RU - Federazione Russa 4.663
SG - Singapore 1.780
CN - Cina 1.357
BR - Brasile 1.277
IE - Irlanda 1.029
SE - Svezia 1.027
IT - Italia 680
HK - Hong Kong 440
DE - Germania 427
UA - Ucraina 317
FR - Francia 303
VN - Vietnam 236
PL - Polonia 215
FI - Finlandia 206
GB - Regno Unito 191
IN - India 114
AR - Argentina 81
CA - Canada 79
BD - Bangladesh 64
MX - Messico 50
BE - Belgio 42
ZA - Sudafrica 39
JP - Giappone 38
EC - Ecuador 35
TR - Turchia 35
NL - Olanda 33
IQ - Iraq 31
UZ - Uzbekistan 26
CO - Colombia 24
ID - Indonesia 24
ES - Italia 23
MA - Marocco 23
AT - Austria 22
PK - Pakistan 22
VE - Venezuela 20
IR - Iran 17
CZ - Repubblica Ceca 15
PH - Filippine 15
UY - Uruguay 15
EG - Egitto 14
TN - Tunisia 14
PE - Perù 13
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
AL - Albania 12
AU - Australia 12
CL - Cile 12
JM - Giamaica 12
KE - Kenya 10
AZ - Azerbaigian 9
SA - Arabia Saudita 9
BO - Bolivia 8
KZ - Kazakistan 8
MY - Malesia 8
RO - Romania 8
JO - Giordania 7
KR - Corea 7
LT - Lituania 7
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
HN - Honduras 6
OM - Oman 6
GY - Guiana 5
KH - Cambogia 5
RS - Serbia 5
SV - El Salvador 5
AM - Armenia 4
CR - Costa Rica 4
DZ - Algeria 4
LB - Libano 4
LU - Lussemburgo 4
MN - Mongolia 4
NI - Nicaragua 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CH - Svizzera 3
ET - Etiopia 3
GR - Grecia 3
IL - Israele 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GE - Georgia 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BG - Bulgaria 1
Totale 23.435
Salva come PNG Salva come JPEG
Città #
Ashburn 1.366
Moscow 1.305
Singapore 1.033
Dublin 1.029
Chandler 736
Dallas 690
Jacksonville 648
Nyköping 513
Beijing 487
Hong Kong 439
San Jose 341
Council Bluffs 252
Warsaw 201
The Dalles 189
Messina 187
Princeton 170
Los Angeles 167
Boardman 162
Lauterbourg 160
Cambridge 157
Medford 153
Dearborn 144
Ann Arbor 139
Des Moines 128
São Paulo 103
Munich 101
Buffalo 82
Ho Chi Minh City 80
New York 78
Santa Clara 70
Jinan 58
Hanoi 53
Woodbridge 53
Frankfurt am Main 46
Wilmington 44
Redondo Beach 42
Guangzhou 41
Tianjin 41
Shenyang 40
Brussels 39
Belo Horizonte 37
Catania 36
Turku 35
Atlanta 33
Orem 33
San Mateo 33
Rio de Janeiro 32
Bremen 30
Tokyo 30
Zhengzhou 30
Brooklyn 29
Hyderabad 29
Lancaster 28
London 28
Düsseldorf 26
Hebei 26
Houston 26
Curitiba 25
Shanghai 25
Denver 24
Milan 24
Porto Alegre 24
Rome 24
Seattle 24
Brasília 23
Chennai 23
Columbus 23
Helsinki 23
Montreal 23
Tashkent 22
Ningbo 21
Johannesburg 20
Shenzhen 20
Boston 19
Nanjing 19
Stockholm 19
Chicago 17
Haikou 17
Pune 17
San Francisco 17
Taizhou 17
Sorocaba 15
Washington 15
Baghdad 14
Dong Ket 14
Manchester 14
Ottawa 14
Fortaleza 13
Mexico City 13
Quito 13
Campinas 12
Guarulhos 12
Guayaquil 12
Montevideo 12
Phoenix 12
Amsterdam 11
Campo Grande 11
Goiânia 11
Hefei 11
Jakarta 11
Totale 13.038
Salva come PNG Salva come JPEG
Nome #
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 348
Inositolo e sindrome metabolica in menopausa 302
Dietary management of skin health: The role of genistein 272
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 251
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 244
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 241
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 231
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 229
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 223
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 220
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 215
Italian risk factor-based screening for gestational diabetes. 210
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 209
Myo-inositol and melatonin in the menopausal transition 209
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 208
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 207
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 205
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 203
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 200
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 197
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 196
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 195
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 194
Myo-inositol may prevent gestational diabetes in PCOS women 194
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 193
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women 192
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 191
Cardiovascular effects of raloxifene hydrochloride 186
C-reactive protein as an early predictor of gestational diabetes mellitus 185
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 185
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 185
Effects of myo-inositol on glucose variability in women with gestational diabetes 184
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 182
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 181
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 181
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 178
B cell leukaemia/lymphoma-2 protein concentrations during normal pregnancy 176
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 173
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 172
Closed vs. Open Oocyte Vitrification Methods Are Equally Effective for Blastocyst Embryo Transfers: Prospective Study from a Sibling Oocyte Donation Program 172
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 172
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 171
Cardiovascular effects of the phytoestrogen genistein 170
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 170
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 170
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 169
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 169
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 169
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 167
Association of maternal food insecurity before and during pregnancy with fetal structural anomalies: A multicenter case-control study protocol 167
ADAM 12 come marker precoce di preeclampsia 165
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 165
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 165
Compliance with hormone replacement therapy in postmenopausal Sicilian women 164
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 164
Maternal serum PAPP-A as an early marker of obstetric complications? 162
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 161
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 160
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 160
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 160
Differenze socio.demografiche e psicologiche tra gruppi di pazienti in peri e post menopausa 158
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 156
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 155
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 155
Midtrimester amniotic fluid adiponectin in normal pregnancy. 153
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 153
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 150
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 150
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 150
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 148
Effetti del fitoestrogeno genisteina su donne in post-menopausa affette da sindrome metabolica 147
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 145
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 144
Pregnancy outcome following mid-trimester amniocentesis 144
Effects of a new vaginal cream containing visnadine, prenylflavonoids and bovine colostrum on Vaginal Health Index Score and Female Sexual Function Index in post-menopausal sexually active women affected by vaginal dryness: A pilot study 144
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 142
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 141
Effects of genistein aglycone on endometrial hyperplasia in premenopausal women: a randomized controlled trial 141
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 141
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 141
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 140
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 139
La disfunzione diastolica nel diabete gestazionale 138
First- and Second-Trimester ADAM12s in Down Syndrome Screening. 137
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 137
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 135
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 132
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 131
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 131
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 131
Interleukin 31 is involved in intrahepatic cholestasis of pregnancy 131
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 128
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 124
The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women 124
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group 120
The clinical utility of serum uric acid measurements in pre- eclampsia and transient hypertension in pregnancy 117
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 117
Use of diet and myoinositol in postmenopausal women: a new approach to the metabolic syndrome 116
Inflammatory markers in women with a recent history of gestational diabetes mellitus 115
The impact of kidney development on the life course: a consensus document for action 115
Totale 17.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.280
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.205 0 145 29 44 47 15 70 44 35 282 148 346
2022/20233.036 223 283 149 185 252 300 33 177 1.289 16 96 33
2023/2024770 60 108 43 106 62 111 27 30 0 58 21 144
2024/20253.387 68 29 70 221 147 132 54 717 850 238 325 536
2025/202610.784 595 724 733 759 811 2.217 1.282 1.359 1.458 422 186 238
2026/2027956 221 735 0 0 0 0 0 0 0 0 0 0
Totale 23.727